Loading clinical trials...
Loading clinical trials...
Alternation of FOLFOX6 (Oxaliplatin - Leucovorin - Fluorouracil) and FOLFIRI (Irinotecan - Leucovorin - Fluorouracil) as Second Line Treatment of Metastatic Colorectal Cancer
Conditions
Interventions
FOLFIRI regimen
FOLFOX regimen
+4 more
Locations
16
France
Hopital Drevon
Dijon, France
Centre Jean Bernard
Le Mans, France
Centre Hospital Universitaire Hop Huriez
Lille, France
Clinique Saint Jean
Lyon, France
CH Meulan
Meulan-en-Yvelines, France
Intercommunal Hospital
Montfermeil, France
Start Date
April 1, 1999
Last Updated
January 13, 2009
NCT06696768
NCT04704661
NCT05489211
NCT06625775
NCT04657068
NCT06607458
Lead Sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions